CGQGX | FGPGX | CGQGX / FGPGX | |
Total Expense Ratio | 0.63 | 0.50 | 126% |
Annual Report Gross Expense Ratio | 0.68 | 0.50 | 136% |
Fund Existence | 7 years | 5 years | - |
Gain YTD | 17.405 | 17.508 | 99% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 24.4B | 24.4B | 100% |
Annual Yield % from dividends | 0.44 | 0.57 | 78% |
Returns for 1 year | 11.51 | 11.67 | 99% |
Returns for 3 years | 61.68 | 62.35 | 99% |
Returns for 5 years | 41.42 | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIB | 67.02 | 0.80 | +1.21% |
ProShares Ultra Nasdaq Biotechnology | |||
IQQQ | 44.25 | 0.31 | +0.71% |
ProShares Nasdaq-100 High Income ETF | |||
FENY | 23.84 | 0.15 | +0.63% |
Fidelity MSCI Energy ETF | |||
ILS | 20.21 | 0.04 | +0.19% |
Brookmont Catastrophic Bond ETF | |||
XXCH | 32.39 | N/A | N/A |
Direxion Daily MSCI Em Mkt Ex Chn Bl 2X |